-
公开(公告)号:US20230312595A1
公开(公告)日:2023-10-05
申请号:US18328350
申请日:2023-06-02
申请人: AbbVie Inc.
发明人: Ayman Allian , Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmed A. Othman , Michael J. Rozema , Lakshmi Bhagavatula , Patrick J. Marroum , Peter T. Mayer , Ahmad Y. Sheikh , Thomas B. Borchardt , Ben Klünder
IPC分类号: C07D487/14 , A61K47/12 , A61K47/38 , A61K9/00 , A61K31/4985
CPC分类号: C07D487/14 , A61K47/12 , A61K47/38 , A61K9/0053 , A61K31/4985 , C07B2200/13
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US20230058001A1
公开(公告)日:2023-02-23
申请号:US17951334
申请日:2022-09-23
申请人: AbbVie Inc.
发明人: Ayman Allian , Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmed A. Othman , Michael J. Rozema , Lakshmi Bhagavatula , Patrick J. Marroum , Peter T. Mayer , Ahmad Y. Sheikh , Thomas B. Borchardt , Ben Klünder
IPC分类号: C07D487/14 , A61K9/00 , A61K31/4985 , A61K47/12 , A61K47/38
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US20230057084A1
公开(公告)日:2023-02-23
申请号:US17951332
申请日:2022-09-23
申请人: AbbVie Inc.
发明人: Ayman Allian , Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmed A. Othman , Michael J. Rozema , Lakshmi Bhagavatula , Patrick J. Marroum , Peter T. Mayer , Ahmad Y. Sheikh , Thomas B. Borchardt , Ben Klünder
IPC分类号: C07D487/14 , A61K9/00 , A61K31/4985 , A61K47/12 , A61K47/38
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US12110298B2
公开(公告)日:2024-10-08
申请号:US18369272
申请日:2023-09-18
申请人: AbbVie Inc.
IPC分类号: C07D487/14 , A61K9/00 , A61K31/4985 , A61K47/02 , A61K47/12 , A61K47/38 , C07D487/04
CPC分类号: C07D487/14 , A61K9/0053 , A61K31/4985 , A61K47/02 , A61K47/12 , A61K47/38 , C07D487/04 , C07B2200/13
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US20240034740A1
公开(公告)日:2024-02-01
申请号:US18328325
申请日:2023-06-02
申请人: AbbVie Inc.
发明人: Ayman Allian , Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmed A. Othman , Michael J. Rozema , Lakshmi Bhagavatula , Patrick J. Marroum , Peter T. Mayer , Ahmad Y. Sheikh , Thomas B. Borchardt , Ben Klünder
IPC分类号: C07D487/14 , A61K9/00 , A61K31/4985 , A61K47/12 , A61K47/38
CPC分类号: C07D487/14 , A61K9/0053 , A61K31/4985 , A61K47/12 , A61K47/38 , C07B2200/13
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US20230322794A1
公开(公告)日:2023-10-12
申请号:US18329988
申请日:2023-06-06
申请人: AbbVie Inc.
发明人: Ayman Allian , Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmed A. Othman , Michael J. Rozema , Lakshmi Bhagavatula , Patrick J. Marroum , Peter T. Mayer , Ahmad Y. Sheikh , Thomas B. Borchardt , Ben Klünder
IPC分类号: C07D487/14 , A61K47/38 , A61K9/00 , A61K47/12 , A61K31/4985
CPC分类号: C07D487/14 , A61K47/38 , A61K9/0053 , A61K47/12 , A61K31/4985 , C07B2200/13
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US20230312593A1
公开(公告)日:2023-10-05
申请号:US18174738
申请日:2023-02-27
申请人: AbbVie Inc.
发明人: Ayman Allian , Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmed A. Othman , Michael J. Rozema , Lakshmi Bhagavatula , Patrick J. Marroum , Peter T. Mayer , Ahmad Y. Sheikh , Thomas B. Borchardt , Ben Klünder
IPC分类号: C07D487/14 , A61K9/00 , A61K31/4985 , A61K47/12 , A61K47/38
CPC分类号: C07D487/14 , A61K9/0053 , A61K31/4985 , A61K47/12 , A61K47/38 , C07B2200/13
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US20240174682A1
公开(公告)日:2024-05-30
申请号:US18530077
申请日:2023-12-05
申请人: AbbVie Inc.
发明人: Ayman Allian , Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmed A. Othman , Michael J. Rozema , Lakshmi Bhagavatula , Patrick J. Marroum , Peter T. Mayer , Ahmad Y. Sheikh , Thomas B. Borchardt , Ben Klünder , Heidi S. Camp , Robert J. Padley , Jeffrey W. Voss
IPC分类号: C07D487/14 , A61K9/00 , A61K31/4985 , A61K47/02 , A61K47/12 , A61K47/38 , C07D487/04
CPC分类号: C07D487/14 , A61K9/0053 , A61K31/4985 , A61K47/02 , A61K47/12 , A61K47/38 , C07D487/04 , C07B2200/13
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US20230303582A1
公开(公告)日:2023-09-28
申请号:US18174736
申请日:2023-02-27
申请人: AbbVie Inc.
发明人: Ayman Allian , Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmed A. Othman , Michael J. Rozema , Lakshmi Bhagavatula , Patrick J. Marroum , Peter T. Mayer , Ahmad Y. Sheikh , Thomas B. Borchardt , Ben Klünder
IPC分类号: C07D487/14 , A61K9/00 , A61K31/4985 , A61K47/12 , A61K47/38
CPC分类号: C07D487/14 , A61K9/0053 , A61K31/4985 , A61K47/12 , A61K47/38 , C07B2200/13
摘要: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
-
公开(公告)号:US09199992B2
公开(公告)日:2015-12-01
申请号:US14644970
申请日:2015-03-11
申请人: AbbVie Inc.
发明人: Vincent S. Chan , Alan C. Christesen , Timothy A. Grieme , Yi-Yin Ku , Mathew M. Mulhern , Yu-Ming M. Pu
IPC分类号: C07D471/04 , C07C67/10 , C07C67/00 , C07C69/78
CPC分类号: C07D471/04 , C07C67/00 , C07C67/10 , C07C69/78 , C07C69/76
摘要: Provided herein is a process for the preparation of an apoptosis-inducing agent, and chemical intermediates thereof. Also provided herein are novel chemical intermediates related to the process provided herein.
-
-
-
-
-
-
-
-
-